Index
RUT
Market Cap
2.49B
Enterprise Value
2.58B
Income
3.58M
Sales
787.44M
Book/sh
1.49
Cash/sh
1.58
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
2100
IPO
Jul 29, 2020
P/E
712.56
Forward P/E
15.07
PEG
0.62
P/S
3.16
P/B
10.27
P/C
9.67
P/FCF
34.31
EV/EBITDA
21.48
EV/Sales
3.27
Quick Ratio
0.86
Current Ratio
0.86
Debt/Eq
1.45
LT Debt/Eq
1.43
Option/Short
Yes / Yes
EPS (ttm)
0.02
EPS next Y
1.02
EPS next Q
0.22
EPS this Y
28.30%
EPS next Y
23.77%
EPS next 5Y
24.36%
EPS past 3/5Y
- -
Sales past 3/5Y
15.04% 14.84%
EPS Y/Y TTM
106.83%
Sales Y/Y TTM
10.83%
EPS Q/Q
1033.33%
Sales Q/Q
10.52%
Insider Own
53.83%
Insider Trans
-0.01%
Inst Own
46.21%
Inst Trans
-6.70%
ROA
0.30%
ROE
1.46%
ROIC
0.61%
Gross Margin
59.86%
Oper. Margin
1.08%
Profit Margin
0.45%
SMA20
10.93%
SMA50
16.49%
SMA200
15.29%
Trades
Shs Outstand
79.41M
Shs Float
74.90M
52W High
23.30 -34.25%
52W Low
10.21 50.05%
Volatility
3.83% 4.18%
ATR (14)
0.59
RSI (14)
70.21
Beta
0.81
Rel Volume
0.84
Avg Volume
1.71M
Volume
1,430,780
Perf Week
-0.45%
Perf Month
24.55%
Perf Quarter
14.33%
Perf Half Y
16.15%
Perf YTD
-23.28%
Perf Year
-32.21%
Perf 3Y
-32.92%
Perf 5Y
-26.42%
Perf 10Y
-
Prev Close
14.86
Price
15.32
Change %
3.10%
Analysts 12 incl. previous ratings
Rating Distribution 5 Buy · 7 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 04, 2026 Reiterated B BMO Capital Markets
Market Perform $14 → $15 -2.1% Jul 21, 2026 Downgrade M Morgan Stanley
Overweight → Equal-Weight $15 -2.1% Jun 29, 2026 Initiated T TD Cowen
Buy $14 -8.6% May 08, 2026 Reiterated B BMO Capital Markets
Outperform $14 → $17 +11.0% Feb 12, 2026 Downgrade J Jefferies
Buy → Hold $16 +4.4% Feb 03, 2026 Downgrade P Piper Sandler
Overweight → Neutral $20 +30.5% Nov 04, 2025 Reiterated B BMO Capital Markets
Outperform $30 → $24 +56.7% Sep 26, 2025 Initiated S Stephens
Overweight $30 +95.8% Aug 07, 2025 Reiterated B BMO Capital Markets
Outperform $38 → $30 +95.8% Jun 17, 2025 Initiated P Piper Sandler
Overweight $48 +213.3% Apr 22, 2025 Initiated E Exane BNP Paribas
Outperform $54 +252.5% Feb 28, 2025 Downgrade S Stifel
Buy → Hold $58 → $31 +102.3% Jan 03, 2025 Downgrade R Raymond James
Outperform → Mkt Perform Dec 31, 2024 Initiated D DA Davidson
Buy $62 +304.7% Nov 04, 2024 Upgrade J Jefferies
Hold → Buy $35 → $50 +226.4% Jul 23, 2024 Initiated R Robert W. Baird
Outperform $43 +180.7% Mar 01, 2024 Upgrade B BofA Securities
Underperform → Neutral $40 +161.1% Sep 18, 2023 Resumed M Morgan Stanley
Overweight $25 +63.2% Mar 09, 2023 Upgrade B BofA Securities
Underperform → Neutral $16 → $20 +30.5% Feb 09, 2023 Initiated R Raymond James
Outperform $19 +24.0%
Show Previous Ratings
Oct-27-26 08:26PM
Oct-26-26 01:01PM
Oct-20-26 08:05AM
Oct-15-26 04:05PM
08:00AM
11:36AM
Loading…
Oct-09-26 11:36AM
Oct-01-26 08:00AM
Sep-03-26 08:30AM
Aug-13-26 08:00AM
Aug-04-26 08:00AM
01:04AM
Aug-03-26 04:36PM
04:03PM
Jul-30-26 10:05AM
Jul-16-26 09:06AM
04:30PM
Loading…
Jul-14-26 04:30PM
Jul-07-26 06:36AM
(Pharmaceutical Business Review)
Jun-01-26 08:00AM
May-19-26 07:00AM
May-08-26 05:00PM
May-07-26 07:25AM
(Associated Press)
+15.88%
07:00AM
Apr-24-26 01:40PM
Apr-13-26 08:00AM
Apr-08-26 06:10AM
(Pharmaceutical Business Review)
Apr-07-26 08:00AM
Mar-20-26 10:40AM
Mar-17-26 08:30AM
Feb-27-26 08:00AM
Feb-25-26 07:05PM
04:02PM
Loading…
Feb-11-26 04:02PM
01:50PM
09:30AM
08:35AM
08:11AM
07:41AM
(Associated Press Finance)
07:05AM
Feb-05-26 05:40PM
Feb-03-26 08:00AM
08:00AM
Jan-22-26 01:53PM
Jan-12-26 04:05PM
Jan-06-26 09:00AM
08:20AM
Dec-28-25 12:28PM
Dec-05-25 08:00AM
Dec-04-25 09:49PM
Nov-18-25 03:00PM
Nov-17-25 12:20PM
Nov-05-25 06:46AM
Nov-04-25 04:00PM
02:09PM
09:35AM
Nov-03-25 07:52PM
04:01PM
07:15AM
(Associated Press Finance)
07:05AM
Oct-31-25 10:29PM
Oct-30-25 04:00AM
Oct-28-25 10:00AM
09:02AM
Oct-27-25 05:15PM
10:00AM
Oct-23-25 09:55AM
Oct-21-25 08:30AM
Oct-20-25 09:52AM
Oct-14-25 11:00AM
Oct-09-25 08:20AM
Oct-08-25 08:00AM
Oct-06-25 07:30AM
Oct-03-25 04:47AM
Oct-02-25 02:06PM
Sep-26-25 09:46AM
Sep-08-25 02:39PM
07:00AM
Sep-04-25 12:10PM
Aug-26-25 08:00AM
Aug-25-25 06:30AM
Aug-07-25 12:08PM
Aug-06-25 09:30AM
08:20AM
07:19AM
(Associated Press Finance)
07:05AM
Aug-04-25 05:19PM
Jul-31-25 05:55PM
Jul-30-25 10:00AM
Jul-29-25 01:38PM
Jul-28-25 12:10PM
08:00AM
Jul-15-25 12:11PM
Jul-08-25 04:05PM
Jul-02-25 08:51AM
Jun-26-25 08:00AM
Jun-18-25 09:51AM
Jun-10-25 08:00AM
May-19-25 08:00AM
May-09-25 01:48PM
01:46PM
May-08-25 06:45PM
03:29PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DeStefano David Director May 28 '26 Sale 12.75 6,460 82,365 197,572 Jun 01 04:17 PM David DeStefano director May 28 '26 Proposed Sale 12.75 6,460 82,365 May 28 01:40 PM DeStefano David Director Feb 24 '26 Option Exercise 0.00 109,233 0 1,307,500 Feb 26 04:18 PM Young Christopher David President and CEO Feb 23 '26 Buy 12.18 60,000 730,794 60,000 Feb 25 04:15 PM DeStefano David Director Feb 23 '26 Option Exercise 0.00 101,395 0 1,245,379 Feb 25 04:14 PM Rowland Bryan T.R. GENERAL COUNSEL Feb 23 '26 Option Exercise 0.00 6,428 0 14,640 Feb 25 04:13 PM SCHWAB JOHN R CHIEF FINANCIAL OFFICER Feb 23 '26 Option Exercise 0.00 30,305 0 148,682 Feb 25 04:12 PM DeStefano David Director Feb 20 '26 Option Exercise 0.00 113,541 0 1,156,507 Feb 24 04:26 PM SCHWAB JOHN R CHIEF FINANCIAL OFFICER Feb 20 '26 Option Exercise 0.00 39,766 0 126,975 Feb 24 04:26 PM Rowland Bryan T.R. GENERAL COUNSEL Feb 20 '26 Option Exercise 0.00 7,108 0 9,188 Feb 24 04:25 PM Leib Ryan J Chief Accounting Officer Feb 20 '26 Option Exercise 0.00 6,348 0 8,205 Feb 24 04:24 PM ANDERSEN ERIC C. Director Feb 20 '26 Buy 12.91 40,000 516,400 150,341 Feb 23 04:47 PM Westphal Jeffrey Feb 13 '26 Buy 13.08 247,740 3,241,059 247,740 Feb 18 05:22 PM Westphal Jeffrey Feb 17 '26 Buy 12.53 150,000 1,880,235 397,740 Feb 18 05:22 PM Rowland Bryan T.R. GENERAL COUNSEL Feb 10 '26 Option Exercise 0.00 4,088 0 4,680 Feb 12 04:18 PM SCHWAB JOHN R CHIEF FINANCIAL OFFICER Feb 10 '26 Option Exercise 0.00 24,010 0 113,634 Feb 12 04:17 PM Leib Ryan J Chief Accounting Officer Jan 30 '26 Option Exercise 0.00 4,019 0 4,479 Feb 03 04:15 PM
Vertex, Inc. engages in the provision of tax compliance software solutions. The firm offers comprehensive solutions that automate end-to-end indirect tax processes for enterprises and mid-market companies with complex tax transactions. Its software enables tax determination, data management, compliance and reporting, and document management. The company was founded by Ray Westphal and Antoinette Westphal in 1978 and is headquartered in King of Prussia, PA.
CEO Mr. Christopher David Young
Co-Owner & Independent Director Ms. Amanda Westphal Radcliffe
Co-Owner & Independent Director Ms. Stefanie Westphal-Lucas Thompson
Chief Financial Officer Mr. John R. Schwab
Senior VP Mr. Bryan T. R. Rowland